S&P 500   3,325.30 (+1.66%)
DOW   26,768.54 (+0.94%)
QQQ   277.98 (+2.33%)
AAPL   116.01 (+4.33%)
MSFT   206.01 (+1.64%)
FB   280.92 (+4.95%)
GOOGL   1,571.98 (+4.05%)
AMZN   3,222.02 (+1.87%)
TSLA   413.40 (+1.82%)
NVDA   523.52 (+3.65%)
BABA   314.60 (+2.16%)
CGC   18.82 (+2.62%)
GE   7.36 (-0.81%)
MU   50.60 (+1.20%)
AMD   78.45 (+2.68%)
T   26.84 (+1.28%)
F   7.91 (+2.73%)
ACB   4.03 (+5.22%)
GILD   58.79 (+0.12%)
NFLX   510.50 (+4.99%)
NIO   31.86 (+15.81%)
BA   147.97 (-0.11%)
DIS   122.02 (+3.00%)
S&P 500   3,325.30 (+1.66%)
DOW   26,768.54 (+0.94%)
QQQ   277.98 (+2.33%)
AAPL   116.01 (+4.33%)
MSFT   206.01 (+1.64%)
FB   280.92 (+4.95%)
GOOGL   1,571.98 (+4.05%)
AMZN   3,222.02 (+1.87%)
TSLA   413.40 (+1.82%)
NVDA   523.52 (+3.65%)
BABA   314.60 (+2.16%)
CGC   18.82 (+2.62%)
GE   7.36 (-0.81%)
MU   50.60 (+1.20%)
AMD   78.45 (+2.68%)
T   26.84 (+1.28%)
F   7.91 (+2.73%)
ACB   4.03 (+5.22%)
GILD   58.79 (+0.12%)
NFLX   510.50 (+4.99%)
NIO   31.86 (+15.81%)
BA   147.97 (-0.11%)
DIS   122.02 (+3.00%)
S&P 500   3,325.30 (+1.66%)
DOW   26,768.54 (+0.94%)
QQQ   277.98 (+2.33%)
AAPL   116.01 (+4.33%)
MSFT   206.01 (+1.64%)
FB   280.92 (+4.95%)
GOOGL   1,571.98 (+4.05%)
AMZN   3,222.02 (+1.87%)
TSLA   413.40 (+1.82%)
NVDA   523.52 (+3.65%)
BABA   314.60 (+2.16%)
CGC   18.82 (+2.62%)
GE   7.36 (-0.81%)
MU   50.60 (+1.20%)
AMD   78.45 (+2.68%)
T   26.84 (+1.28%)
F   7.91 (+2.73%)
ACB   4.03 (+5.22%)
GILD   58.79 (+0.12%)
NFLX   510.50 (+4.99%)
NIO   31.86 (+15.81%)
BA   147.97 (-0.11%)
DIS   122.02 (+3.00%)
S&P 500   3,325.30 (+1.66%)
DOW   26,768.54 (+0.94%)
QQQ   277.98 (+2.33%)
AAPL   116.01 (+4.33%)
MSFT   206.01 (+1.64%)
FB   280.92 (+4.95%)
GOOGL   1,571.98 (+4.05%)
AMZN   3,222.02 (+1.87%)
TSLA   413.40 (+1.82%)
NVDA   523.52 (+3.65%)
BABA   314.60 (+2.16%)
CGC   18.82 (+2.62%)
GE   7.36 (-0.81%)
MU   50.60 (+1.20%)
AMD   78.45 (+2.68%)
T   26.84 (+1.28%)
F   7.91 (+2.73%)
ACB   4.03 (+5.22%)
GILD   58.79 (+0.12%)
NFLX   510.50 (+4.99%)
NIO   31.86 (+15.81%)
BA   147.97 (-0.11%)
DIS   122.02 (+3.00%)
Log in
OTCMKTS:SSMXY

Sysmex News Headlines

$48.51
+1.09 (+2.30 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$47.39
Now: $48.51▼
$49.13
50-Day Range
$42.55
MA: $47.31▼
$49.67
52-Week Range
$26.29
Now: $48.51▼
$50.55
Volume30,602 shs
Average Volume22,674 shs
Market Capitalization$20.25 billion
P/E Ratio67.38
Dividend Yield0.53%
Beta0.13

Headlines

Sysmex (OTCMKTS SSMXY) News Headlines Today

Source:
SourceHeadline
Sysmex Co. (OTCMKTS:SSMXY) Short Interest Down 77.2% in OctoberSysmex Co. (OTCMKTS:SSMXY) Short Interest Down 77.2% in October
americanbankingnews.com - October 28 at 12:56 PM
Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Expands By 79.8%Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Expands By 79.8%
americanbankingnews.com - October 16 at 7:29 AM
Sysmex (OTCMKTS:SSMXY) Sets New 12-Month High at $50.55Sysmex (OTCMKTS:SSMXY) Sets New 12-Month High at $50.55
americanbankingnews.com - October 14 at 6:38 PM
SYSMEX CORP/ADR (OTCMKTS:SSMXY) Sets New 52-Week High at $48.90SYSMEX CORP/ADR (OTCMKTS:SSMXY) Sets New 52-Week High at $48.90
americanbankingnews.com - October 8 at 6:38 PM
Sysmex Inostics Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient ManagementSysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management
prnewswire.com - September 8 at 7:31 AM
Sysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS TestingSysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance with Standard of Care Tissue-Based RAS Testing
finance.yahoo.com - August 5 at 9:55 AM
Sysmex America Releases Caresphere™ Workflow Solution (WS) Designed to Deliver Efficiency Increases to LabsSysmex America Releases Caresphere™ Workflow Solution (WS) Designed to Deliver Efficiency Increases to Labs
www.prnewswire.com - August 3 at 12:22 PM
Sysmex America Launches XF-1600™: New Automated Flow Cytometer Provides Improved Flexibility and EfficiencySysmex America Launches XF-1600™: New Automated Flow Cytometer Provides Improved Flexibility and Efficiency
finance.yahoo.com - June 17 at 10:07 AM
De Novo Software: Sysmex Partec Will Bundle FCS Express 7 Flow With the CyFlow Cube 6De Novo Software: Sysmex Partec Will Bundle FCS Express 7 Flow With the CyFlow Cube 6
www.finanznachrichten.de - May 25 at 11:55 PM
Sysmex Corp. ADRSysmex Corp. ADR
www.barrons.com - April 25 at 11:59 PM
Sysmex Inostics Updated SafeSEQ Breast Cancer Panel Advances Novel Clinical Uses of ctDNA Through Quantitative TestingSysmex Inostics' Updated SafeSEQ Breast Cancer Panel Advances Novel Clinical Uses of ctDNA Through Quantitative Testing
www.prnewswire.com - March 9 at 5:52 PM
Sysmex 2020: Performance, Capabilities, Goals & Strategies in the Global Diagnostics Industry - ResearchAndMarkets.comSysmex 2020: Performance, Capabilities, Goals & Strategies in the Global Diagnostics Industry - ResearchAndMarkets.com
www.businesswire.com - February 6 at 8:38 AM
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimers Disease Using BloodSysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood
www.benzinga.com - December 8 at 10:24 PM
This page was last updated on 10/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.